Compare medicines
Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.
| Attribute | ||
|---|---|---|
| In short | Fast-acting mealtime insulin. | Once-daily long-acting background insulin. |
| Body system | Diabetes & Weight | Diabetes & Weight |
| Drug class | Insulins | Insulins |
| Supply | Prescription only | Prescription onlyWHO essential medicine |
| Main uses | Type 1 diabetes (mealtime and pumps), Type 2 diabetes needing mealtime insulin, Diabetic ketoacidosis (IV regimens use soluble insulin) | Type 1 diabetes (basal), Type 2 diabetes |
| How it works | Works fast to cover the sugar from a meal. | Releases slowly from under the skin to keep blood sugar steady all day and night. |
| Starts working | 10–20 minutes; peak 1–3 hours | 1–2 hours, no peak |
| Half-life | Duration 3–5 hours | Duration about 24 hours |
| Typical adult dose | Individual — given 0–15 minutes before meals, adjusted to carbohydrate intake. | Individual — commonly started at 10 units (or 0.1–0.2 units/kg) once a day and adjusted to fasting glucose. |
| Forms | Pen injection, Vial, Pump cartridge | Pen injection, Vial, Cartridge |
| Common side effects | Low blood sugar, Injection-site reactions | Low blood sugar, Weight gain, Injection-site lumps |
| Serious side effects | Severe hypoglycaemia, Low potassium | Severe hypoglycaemia, Low potassium (rare) |
| Don't take if | — | — |
| Alcohol | — | — |
| Pregnancy | Generally considered safeUsed routinely in pregnancy. | Generally considered safeInsulin is the mainstay of diabetes treatment in pregnancy. |
| Breastfeeding | — | — |
| In use since | 1999 | 2000 |
| Brand names | United States: NovoLog, FiaspUnited Kingdom: NovoRapid, FiaspIndia: NovoRapid | United States: Lantus, Toujeo, Basaglar, SemgleeUnited Kingdom: Lantus, Toujeo, AbasaglarIndia: Lantus, Basalog, Glaritus |
| Legal status | — | — |
| ATC code | A10AB05 | A10AE04 |
Taken together
- MinorInsulin aspart + Insulin glargine: More risk of low blood sugar
Both medicines lower blood sugar; combinations are common but hypos become more likely.